0000950123-24-011486.txt : 20241114 0000950123-24-011486.hdr.sgml : 20241114 20241114075657 ACCESSION NUMBER: 0000950123-24-011486 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 EFFECTIVENESS DATE: 20241114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Fund Management, LLC CENTRAL INDEX KEY: 0001637359 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16844 FILM NUMBER: 241457259 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: Omega Fund Management (US) Inc. DATE OF NAME CHANGE: 20150320 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001637359 XXXXXXXX 09-30-2024 09-30-2024 false Omega Fund Management, LLC
888 Boylston St., Suite 1111 Boston MA 02199
13F HOLDINGS REPORT 028-16844 N
Alexia Pearsall Chief Financial Officer, Omega Fund Management, LLC 617.921.2117 /s/ Alexia Pearsall Boston MA 11-14-2024 0 11 160008732 false
INFORMATION TABLE 2 37113.xml INFORMATION TABLE FOR FORM 13F Alumis Inc Common Stock 022307102 6976422 653223 SH SOLE 653223 0 0 Bicara Therapeutics Inc. Common Stock 055477103 56152436 2204650 SH SOLE 2204650 0 0 enGene Holdings Inc. Common Stock 29286M105 7103956 1076357 SH SOLE 1076357 0 0 enGene Holdings Inc. Warrant 29286M113 675154 321502 SH SOLE 321502 0 0 Ikena Oncology Common Stock 45175G108 3890983 2249123 SH SOLE 2249123 0 0 Immunic Inc Common Stock 4525EP101 2950464 1788160 SH SOLE 1788160 0 0 Lexeo Therapeutics Common Stock 52886X107 21297372 2355904 SH SOLE 2355904 0 0 Nuvation Bio Common Stock Class A 67080N101 29935659 13072340 SH SOLE 13072340 0 0 Replimune Group Common Stock 76029N106 26976056 2461319 SH SOLE 2461319 0 0 Sana Biotechnology, Inc. Common Stock 799566104 3510000 843750 SH SOLE 843750 0 0 Syros Pharmaceuticals Common Stock 87184Q206 540231 251270 SH SOLE 251270 0 0